Hepatitis C therapy before and after liver transplantation
Norah A. Terrault – 29 September 2008
Do we really need long‐term hepatitis B hyperimmune globulin? What are the alternatives?
John R. Lake – 29 September 2008
The natural history of recurrent hepatitis C and what influences this
Edward J. Gane – 29 September 2008
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow‐up
Ashokkumar Jain, Vrishali P. Patil, John Fung – 29 September 2008
Postoperative issues and outcome for acute liver failure
John G. O'Grady – 29 September 2008
High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation
Minna Ilmakunnas, Eija M. Tukiainen, Ari Rouhiainen, Heikki Rauvala, Johanna Arola, Arno Nordin, Heikki Mäkisalo, Krister Höckerstedt, Helena Isoniemi – 29 September 2008 – High mobility group box 1 protein (HMGB1), a cytokine actively secreted by phagocytes and passively released from necrotic cells, is an inflammatory mediator in experimental hepatic ischemia/reperfusion injury. We characterized its expression in human liver transplantation.
Long‐term improvement in health‐related quality of life after orthotopic liver transplantation
Amy A. Dan, Zobair M. Younossi – 29 September 2008
Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma
Mauricio Silva, Angel Moya, Marina Berenguer, Fernando Sanjuan, Rafael López‐Andujar, Eugenia Pareja, Rodrigo Torres‐Quevedo, Victoria Aguilera, Eva Montalva, Manuel De Juan, Angelo Mattos, Martín Prieto, José Mir – 29 September 2008 – Orthotopic liver transplantation (OLT) selection for patients with hepatocellular carcinoma (HCC) is a matter of debate. The Milan criteria (MC) have been largely adopted by the international community.
Aortohepatic conduits: A personal commentary
Andreas G. Tzakis – 29 September 2008
Risk of malignant neoplasms after liver transplantation: A population‐based study
Fredrik Åberg, Eero Pukkala, Krister Höckerstedt, Risto Sankila, Helena Isoniemi – 29 September 2008 – Posttransplant malignancies have become a serious long‐term complication after liver transplantation. Our aim was to compare the incidence of posttransplant cancers with national cancer incidence rates. The study included all Finnish liver transplant patients transplanted at the Helsinki University Central Hospital between 1982 and 2005. The cohort was linked with the nationwide Finnish Cancer Registry.